INSIGHTS ON PHARMACEUTICAL LOGISTICS

• The Future Of RNA Manufacturing Starts With Raw Material Innovation

  Amid the mRNA and oligonucleotide therapeutic boom, sponsors and manufacturers are exploring how to make critical raw materials—capping agents, lipid nanoparticles, and RNA polymerase—more effective.

• Windsor Framework: What Is It?

  Learn about the Windsor Framework and how it addresses the challenges of medicine supply chains between the UK and the EU, creating stability and certainty in the post-Brexit world.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• Empowering Patients With Self-Administration Drug Delivery Devices

  Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

• Moving Batch Release Into The Fast Lane

  1/21/2026

  Complex supply chains and fragmented systems slow batch release, delaying patient access and revenue goals. Learn how automation and centralized data improve compliance and accelerate delivery.

• Four Reasons You Should Choose Lyophilization for Your Next Project

  12/10/2025

  Lyophilization ensures product stability, extends shelf life, supports sensitive formulations, and simplifies storage and transport, making it a critical choice for modern drug development projects.

• Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters

  11/11/2025

  Explore how a new, climate-neutral manufacturing facility strengthens biopharma supply chains. Understand the benefits of its advanced filtration technologies and commitment to environmental sustainability.

• Fast-Track Innovation, Address CMC Challenges In Expedited Pathways

  1/26/2026

  Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.